MARKET

CURX

CURX

Curanex Pharmaceuticals
NASDAQ
--
0.00
0.00%
Closed
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
No Data
About CURX
More
Curanex Pharmaceuticals Inc is a developmental stage pharmaceutical company. The Company engaged in discovering, developing, and commercializing botanical drugs to treat patients suffering from inflammatory diseases and to develop therapies that offers potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections. Its lead drug candidate, Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant. Its drug development pipelines encompass seven various therapeutic areas: ulcerative colitis, atopic dermatitis, COVID-19, diabetes, NAFLD, gout, and acne. Phyto-N is being developed as an orally administered alternative for patients with moderate to severe ulcerative colitis. The Company's two botanical drugs include Veregen (sinecatechins) and Fulyzaq/Mytesi (crofelemer).
Recently
Symbol
Price
%Change

Webull offers Curanex Pharmaceuticals Inc stock information, including NASDAQ: CURX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CURX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CURX stock methods without spending real money on the virtual paper trading platform.